A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present)
Authors:
- 26 February 2020
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Patents
- Vol. 30 (5) , 341-350
Abstract
Introduction: Discoidin domain receptor 1 (DDR1) is a collagen-activated receptor tyrosine kinase. Upon collagen binding, DDR1 undergoes tyrosine autophosphorylation, which consequently triggers downstream genetic and cellular pathways and plays critical roles in regulation of cellular morphogenesis, differentiation, proliferation, adhesion, migration, and invasion. Increasing evidence suggests the potential roles of DDR1 in various human diseases including cancer, fibrosis, atherosclerosis, and other inflammatory disorders. Modulating the activity of DDR1 may be considered as a new therapeutic strategy for human cancer and inflammation-related diseases. Areas covered: This article summarizes current progress on the development of selective DDR1 inhibitors and their potential therapeutic application during the period from 2014 to 2019. Expert opinion: DDR1 is closely linked to a variety of human diseases, including fibrotic disorders, atherosclerosis, and cancer etc. Thus, DDR1 has been considered as a new potential target for drug discovery. A number of DDR1 inhibitors have been identified in the past 5 years, but most of them display relatively broad inhibition across the kinome. New generation DDR1 inhibitors targeting the allosteric sites outside of the canonical ATP-binding pocket or extracellular domain (allosteric inhibitors) may offer a new opportunity for selective DDR1 inhibition therapy development.Keywords
This publication has 55 references indexed in Scilit:
- Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transitionMedical Oncology, 2013
- Discoidin Domain Receptors Promote α1β1- and α2β1-Integrin Mediated Cell Adhesion to Collagen by Enhancing Integrin ActivationPLOS ONE, 2012
- Discoidin Domain Receptor 1 Is a Major Mediator of Inflammation and Fibrosis in Obstructive NephropathyThe American Journal of Pathology, 2011
- Identification of Receptor Tyrosine Kinase, Discoidin Domain Receptor 1 (DDR1), as a Potential Biomarker for Serous Ovarian CancerInternational Journal of Molecular Sciences, 2011
- Feedback regulation of EGFR signalling: decision making by early and delayed loopsNature Reviews Molecular Cell Biology, 2011
- Discoidin Domain Receptor-1 Deficiency Attenuates Atherosclerotic Calcification and Smooth Muscle Cell-Mediated MineralizationThe American Journal of Pathology, 2009
- Crystallographic Insight into Collagen Recognition by Discoidin Domain Receptor 2Structure, 2009
- Identification of Disulfide-linked Dimers of the Receptor Tyrosine Kinase DDR1Journal of Biological Chemistry, 2008
- Collagen I–mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1Journal of Cell Biology, 2008
- A Discoidin Domain Receptor 1/SHP-2 Signaling Complex Inhibits α2β1-Integrin–mediated Signal Transducers and Activators of Transcription 1/3 Activation and Cell MigrationMolecular Biology of the Cell, 2006